Literature DB >> 25161947

Retinal nerve fiber layer thickness changes in obstructive sleep apnea syndrome: one year follow-up results.

Mehmet Ozgur Zengin1, Ibrahim Tuncer2, Eyyup Karahan2.   

Abstract

AIM: To investigate the retinal nerve fiber layer (RNFL) thickness changes in patients with obstructive sleep apnea syndrome (OSAS) for one year follow-up. To discuss the possibility of detecting tendency of glaucoma in this population by using spectral domain optical coherence tomography (3D-OCT-2000 Spectral domain).
METHODS: After polysomnographic study, all subjects (64 OSAS patients and 40 controls) underwent detailed ophthalmological examination. After these examinations, patients with glaucoma and patients who had ophthalmological and/or systemic disease were excluded from the study. Totally, 20 patients in OSAS group and five patients in controls were excluded from the study in the first examination and follow-up period. The RNFL thickness was assessed with OCT. Forty-four OSAS patients and 35 control subjects were followed up 12mo. RNFL thickness change and OSAS patients were evaluated for severity of disease by Apnea-Hypopnea Index (AHI).
RESULTS: Forty-four OSAS patients and 35 controls were enrolled in the study. Statistically significance was found between OSAS patients and controls at the 12(th) mo. Average RNFL thickness was found to be significantly lower in last measurements in OSAS patients when compared with first measurements and control subjects (P<0.001, 0.002, respectively). There was a statistically significant correlation among AHI, and RNFL thickness (P<0.05).
CONCLUSION: The results suggest that the patients with OSAS were related with a proportional decrease in the RNFL thickness. These patients should be followed up regularly for glaucomatous changes. Detecting more RNFL thinning in severe OSAS was important.

Entities:  

Keywords:  obstructive sleep apnea syndrome; optical coherence tomography; retinal nerve fiber layer thickness

Year:  2014        PMID: 25161947      PMCID: PMC4137211          DOI: 10.3980/j.issn.2222-3959.2014.04.22

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  24 in total

1.  [Retinal nerve fiber layer thickness alterations in patients with obstructive sleep apnea].

Authors:  Pilar Calvo; Blanca Ferrández; Antonio Ferreras; José María Marín
Journal:  Arch Soc Esp Oftalmol       Date:  2012-01

2.  The assessment of sleep apnoea as a risk factor in glaucoma.

Authors:  Tejaswini Prashant Khandgave; Neelam Puthran; Avinash B Ingole; Anjali D Nicholson
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Evaluation of the visual function in obstructive sleep apnea syndrome patients and normal-tension glaucoma by means of the multifocal visual evoked potentials.

Authors:  Esperanza Gutiérrez-Díaz; Consuelo Pérez-Rico; María Josefa de Atauri; Enrique Mencía-Gutiérrez; Román Blanco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-14       Impact factor: 3.117

4.  High prevalence of glaucoma in patients with sleep apnea syndrome.

Authors:  D S Mojon; C W Hess; D Goldblum; J Fleischhauer; F Koerner; C Bassetti; J Mathis
Journal:  Ophthalmology       Date:  1999-05       Impact factor: 12.079

5.  Appearance of the optic disk and retinal nerve fiber layer in atherosclerosis and arterial hypertension: an experimental study in rhesus monkeys.

Authors:  S S Hayreh; J B Jonas
Journal:  Am J Ophthalmol       Date:  2000-07       Impact factor: 5.258

Review 6.  The role of age and cardiovascular disease in glaucomatous optic neuropathy.

Authors:  S S Hayreh
Journal:  Surv Ophthalmol       Date:  1999-06       Impact factor: 6.048

7.  Prevalence of glaucoma in patients with obstructive sleep apnoea--a cross-sectional case-series.

Authors:  R E Bendel; J Kaplan; M Heckman; P A Fredrickson; S-C Lin
Journal:  Eye (Lond)       Date:  2007-05-04       Impact factor: 3.775

8.  Twenty-four hour (Nyctohemeral) rhythm of intraocular pressure and ocular perfusion pressure in normal-tension glaucoma.

Authors:  Elisabeth Renard; Karine Palombi; Claude Gronfier; Jean-Louis Pepin; Christian Noel; Christophe Chiquet; Jean-Paul Romanet
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-13       Impact factor: 4.799

9.  Retinal nerve fiber thickness is reduced in sleep apnea syndrome.

Authors:  Sasan Moghimi; Aliasghar Ahmadraji; Hamed Sotoodeh; Khosro Sadeghniat; Maryam Maghsoudipour; Ghasem Fakhraie; Golshan Latifi; Nariman Nassiri; Joann A Giaconi
Journal:  Sleep Med       Date:  2012-09-02       Impact factor: 3.492

10.  Continuous positive airway pressure therapy is associated with an increase in intraocular pressure in obstructive sleep apnea.

Authors:  Stefan Kiekens; Tanja Coeckelbergh; Marie-José Tassignon; Paul van de Heyning; Johan Verbraecken
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

View more
  19 in total

1.  Evaluation of effects of positive airway pressure treatment on retinal fiber thickness and visual pathways using optic coherence tomography and visual evoked potentials in the patients with severe obstructive sleep apnea syndrome.

Authors:  Melike Batum; Ayşın Kısabay; Hüseyin Mayalı; Tuğba Göktalay; Emin Kurt; Deniz Selçuki; Hikmet Yılmaz
Journal:  Int Ophthalmol       Date:  2020-06-06       Impact factor: 2.031

Review 2.  The association between ophthalmologic diseases and obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Leh-Kiong Huon; Stanley Yung-Chuan Liu; Macario Camacho; Christian Guilleminault
Journal:  Sleep Breath       Date:  2016-05-26       Impact factor: 2.816

3.  Retinal nerve fiber layer thickness changes in obstructive sleep apnea syndrome: a systematic review and Meta-analysis.

Authors:  Jia-Song Wang; Hua-Tao Xie; Ye Jia; Ming-Chang Zhang
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

4.  Retinal and choroidal thickness measurements in obstructive sleep apnea: impacts of continuous positive airway pressure treatment.

Authors:  P Naranjo-Bonilla; María C Muñoz-Villanueva; R Giménez-Gómez; B Jurado-Gámez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-23       Impact factor: 3.117

5.  Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Authors:  Evangelia Chalkiadaki; Konstantinos Andreanos; Efthymios Karmiris; Chrysoula Florou; Xanthi Tsiafaki; Anastasia Amfilochiou; Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou
Journal:  Int Ophthalmol       Date:  2020-11-17       Impact factor: 2.031

6.  Diurnal changes in retinal nerve fiber layer thickness with obstructive sleep apnea/hypopnea syndrome.

Authors:  Niphon Chirapapaisan; Techawit Likitgorn; Mintra Pleumchitchom; Darin Sakiyalak; Wish Banhiran; Manatsawin Saiman; Wanicha Chuenkongkaew
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

7.  Evaluation of retinal nerve fiber layer, ganglion cell layer, and optic nerve head morphological parameters in patients with obstructive sleep apnea and comparison with normal population.

Authors:  Vandhana Sundaram; Sujithra Haridas; Meenakshi Dhar; C P Harikrishnan
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

8.  Evaluation of Retinal Nerve Fiber Layer Thickness and Optic Nerve Head Parameters in Obstructive Sleep Apnoea Patients.

Authors:  Qi Zhe Ngoo; Nazihatul Fikriah A; Baharudin A; Wan Hazabbah Wh
Journal:  Korean J Ophthalmol       Date:  2021-06-04

9.  The Effect of Ocular Perfusion Pressure on Retinal Thickness in Young People with Presumed Systemic Hypotension.

Authors:  Naazia Vawda; Alvin Munsamy
Journal:  Vision (Basel)       Date:  2021-07-14

10.  Prospective evaluation of the comorbidity of obstructive sleep apnea in patients with glaucoma.

Authors:  Yuan-Hsi Chan; Lan-Hsin Chuang; Chung-Chieh Yu; Yu-Lun Lo; Henry S L Chen; Pei-Wei Huang; Ling Yeung; Chi-Chun Lai
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.